PKI PerkinElmer, Inc. (United States)

86.560.46 (+0.53%)
Close: September 20, 2019

Quote

Previous Close
$86.56
Day Range
$86.23-$87.63
52 Week Range
$71.83-$103.00
Volume
707,694
Avg Volume
602,116
Dividend TTM
$0.28 (0.32%)
Ex-Dividend Date
2019-10-17

Valuation

Market Cap
$9.61B
Enterprise Value (EV)
$11.34B
PE Ratio
37.92
EV/EBITDA
20.57
Price/Sales
3.46
Price/Book
3.72
PEG Ratio
3.83

Financials

Revenue
$2.78B
Gross Profit
$1.25B
EBITDA
$551.56M
EPS, ttm
$2.28
Profit Margin
8.60%
Revenue/Employee
$222.24K
Next Earnings Date
10/31/2019 (39 days)
Debt to Equity
73%
Debt
$1.89B
Cash
$163.11M
Net Debt
$1.73B

Performance

Beta
1.29
200 Day Moving Avg
$89.53
50 Day Moving Avg
$86.24
52 Week Change
-10.40%
YTD Change
13.07%
1 Month Change
3.69%
3 Month Change
-9.22%
6 Month Change
-11.22%
1 Year Change
-10.40%
2 Year Change
56.28%
5 Year Change
123.37%

Share Count

Shares Outstanding
111.1M
Float
110.1M
Restricted Shares
988.8K
Restricted Shares, %
0.89%

PerkinElmer, Inc. (United States) Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Robert F. Friel

Website: http://www.perkinelmer.com

Description: PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Employees: 12,500